• 1
    Anderson E,Clarke RB. Steroid receptors and cell cycle in normal mammary epithelium. J Mammary Gland Biol Neoplasia 2004; 9: 313.
  • 2
    Försti A,Zhao C,Israelsson E,Dahlman-Wright K,Gustafsson JA,Hemminki K. Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association. Breast Cancer Res Treat 2003; 79: 40913.
  • 3
    Gold B,Kalush F,Bergeron J,Scott K,Mitra N,Wilson K,Ellis N,Huang H,Chen M,Lippert R,Halldorsson BV,Woodworth B, et al. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 2004; 64: 8891900.
  • 4
    Maguire P,Margolin S,Skoglund J,Sun XF,Gustafsson JA,Borresen-Dale AL,Lindblom A. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res Treat 2005; 94: 14552.
  • 5
    Rosenkranz K,Hinney A,Ziegler A,Hermann H,Fichter M,Mayer H,Siegfried W,Young JK,Remschmidt H,Hebebrand J. Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab 1998; 83: 45247.
  • 6
    Sundarrajan C,Liao WX,Roy AC,Ng SC. Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 2001; 86: 1359.
  • 7
    Eastwood H,Brown KM,Markovic D,Pieri LF. Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa. Mol Psychiatry 2002; 7: 869.
  • 8
    Lambert JC,Harris JM,Mann D,Lemmon H,Coates J,Cumming A,St-Clair D,Lendon C. Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 2001; 306: 1937.
  • 9
    Hu YF,Lau KM,Ho SM,Russo J. Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. Int J Oncol 1998; 12: 12258.
  • 10
    Skliris GP,Carder PJ,Lansdown MR,Speirs V. Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling? Br J Cancer 2001; 84: 10958.
  • 11
    Speirs V,Parkes AT,Kerin MJ,Walton DS,Carleton PJ,Fox JN,Atkin SL. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res 1999; 59: 5258.
  • 12
    Fuqua SA,Schiff R,Parra I,Friedrichs WE,Su JL,McKee DD,Slentz-Kesler K,Moore LB,Willson TM,Moore JT. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res 1999; 59: 54258.
  • 13
    Speirs V,Kerin MJ. Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 2000; 87: 4059.
  • 14
    Omoto Y,Kobayashi Y,Nishida K,Tsuchiya E,Eguchi H,Nakagawa K,Ishikawa Y,Yamori T,Iwase H,Fujii Y,Warner M,Gustafsson JA, et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun 2001; 285: 3407.
  • 15
    Hunter DJ,Riboli E,Haiman CA,Albanes D,Altshuler D,Chanock SJ,Haynes RB,Henderson BE,Kaaks R,Stram DO,Thomas G,Thun MJ, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 2005; 5: 97785.
  • 16
    Calle EE,Rodriguez C,Jacobs EJ,Almon ML,Chao A,McCullough ML,Feigelson HS,Thun MJ. The American Cancer Society Nutrition Cohort: rationale, study design and baseline characteristics. Cancer 2002; 94: 2490501.
  • 17
    Riboli E,Hunt KJ,Slimani N,Ferrari P,Norat T,Fahey M,Charrondiere UR,Hemon B,Casagrande C,Vignat J,Overvad K,Tjonneland A, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 111324.
  • 18
    Colditz GA,Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer 2005; 5: 38896.
  • 19
    Rexrode K,Lee I,Cook N,Hennekens C,Buring J. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 2000; 9: 1927.
  • 20
    Kolonel L,Henderson B,Hankin J,Nomura A,Wilkens L,Pike M,Stram D,Monroe K,Earle M,Nagamine F. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000; 151: 34657.
  • 21
    Stram DO,Haiman CA,Hirschhorn JN,Altshuler D,Kolonel LN,Henderson BE,Pike MC. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003; 55: 2736.
  • 22
    Thellenberg-Karlsson C,Lindstrom S,Malmer B,Wiklund F,Augustsson-Balter K,Adami HO,Stattin P,Nilsson M,Dahlman-Wright K,Gustafsson JA,Gronberg H. Estrogen receptor beta polymorphism is associated with prostate cancer risk. Clin Cancer Res 2006; 12: 193641.
  • 23
    Packer BR,Yeager M,Staats B,Welch R,Crenshaw A,Kiley M,Eckert A,Beerman M,Miller E,Bergen A,Rothman N,Strausberg R, et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004; 32: D52832 [Database issue].
  • 24
    Kraft P,Cox D,Paynter R,Hunter D,De Vivo I. Accounting for haplotype uncertainty in association studies: a comparison of simple and flexible techniques. Genet Epidemiol 2005; 28: 26172.
  • 25
    Zaykin D,Westfall P,Young S,Karnoub M,Wagner M,Ehm M. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53: 7991.
  • 26
    Westfall P,Zaykin D,Young S. Multiple tests for genetic effects in association studies. In: Looney S, ed. Biostatistical methods. Totowa, NJ: Humana Press, 2002; 143168.
  • 27
    Gauderman WJ. Sample size requirements for matched case–control studies of gene-environment interaction. Stat Med 2002; 21: 3550.
  • 28
    Petryshen T,Kirby A,Ainscow M, available at